FOR IMMEDIATE RELEASE…Oct. 6, 2015…SAN DIEGO…bioTheranostics, Inc., a leader in …
Individualizing cancer care and improving patients’ lives by translating scientific discovery into novel molecular tests.
In ER+ early-stage breast cancer
The only robust, validated tool to help with clinical decision-making for extended endocrine treatment
Actionable genomic information for accurate diagnosis and treatment of metastatic with CancerTYPE ID